Second Sight Medical (NSDQ:EYES) announced today that it will wind down its operations amid the financial shock of the coronavirus pandemic. The Los Angeles–based company will lay off 84 of its 108 employees and will retain an adviser experienced in winding down operations to guide the board on the next steps. Company officials expect additional layoffs. […]
CMS recommends postponing most elective procedures
The Centers for Medicare and Medicaid Services (CMS) released guidance late yesterday asking healthcare providers to postpone adult elective surgeries and procedures, including dental procedures, until further notice. The move is an attempt to preserve the supply of ventilators and personal protective equipment such as masks and gowns while protecting patients and staff from exposure […]
Sight Sciences raises $30m in Series E round
Growth-stage ophthalmology and optometry device developer Sight Sciences announced today that it closed a Series E preferred stock financing round totaling over $30 million. The Menlo Park, Calif.–based company — which develops treatments for glaucoma and dry eye disease — said in a news release that the proceeds from the funding are earmarked for clinical […]
Eyebrain Medical raises $23.8m
Eyebrain Medical yesterday filed an amendment to its SEC Form D to confirm the sale of more than $23.8 million in an equity offering. The offering is slated to collect just shy of $24 million, leaving the Costa Mesa, Calif.-based company with $180,026 remaining to be sold. Eyebrain Medical made the first sale on July […]
Ocular Therapeutix dips on big losses, missed projections
Ocular Therapeutix (NSDQ:OCUL) shares were marginally down today on fourth-quarter results that came up short the consensus forecast after massive losses. The Bedford, Mass.-based ophthalmic insert maker posted losses of $26 million, or -53¢ per share, on sales of $2.3 million for the three months ended Dec. 31, 2019, for a 49.5% bottom-line slide despite nearly […]
Alcon launches Vivity intraocular lens in Europe
Alcon (NYSE:ALC) today said it launched its Vivity intraocular lens in Europe. The Vivity lens is a non-diffractive lens that reduces a cataract patient’s dependency on glasses. It is available in spherical and topic designs and allows for high-quality vision at far and intermediate ranges, according to the company. “We are excited to introduce Vivity because […]
Changes at the top for Zeiss ophthalmic biz
Carl Zeiss Meditec announced today that Jim Mazzo will retire from his role as president of ophthalmic devices and head of the ophthalmic devices strategic business unit. Mazzo is slated to continue supporting Zeiss as an advisor, having spent over 40 years in the ophthalmic industry and more than three with Zeiss. His retirement is […]
Glaukos down despite Street-beating Q4
Glaukos (NYSE:GKOS) shares plummeted today despite fourth-quarter results that beat the consensus forecast. GKOS shares dropped down -27.4% at $44.60 per share in early-morning trading today. The San Clemente, Calif.–based ophthalmic medical technology and pharmaceutical company posted profits of $36.6 million, or 84¢ per share, on sales of $65.8 million for the three months ended Dec. […]
These young medtech companies raised the most money in 2019
Medical device industry insiders may very well remember 2019 as the year that IPOs came back — but another sign that the U.S. economy has left the Great Recession far behind. Among the top investment deals in the space, half involved public offerings, according to the MoneyTree report from PricewaterhouseCoopers (PwC) and CB Insights. Total investments […]
Verily, Santen do a JV for ophthalmological devices
Santen Pharmaceutical (OTC:SNPHY) and Verily, an Alphabet (NSDQ:GOOGL) company, announced that they are entering into a joint venture to focus on applying microelectronics and scalable digital technologies to ophthalmology. Osaka, Japan-based Santen and San Francisco-based Verily say they want to improve eye health globally. According to a news release, the joint venture is slated to combine […]
Staar Surgical wins supplemental lens approval for Evo, Evo+, Visian
Staar Surgical (NSDQ:STAA) announced today that it won CE Mark approval for use of its three ICL lenses as supplemental lenses in post-cataract intraocular lenses surgery patients (pseudophakics). Lake Forest, Calif.-based Staar Surgical’s Evo, Evo+ and Visian lenses all earned the European approval. The Evo/Evo+ and Visian devices are implantable collamer lenses designed to treat myopia […]
- 1
- 2
- 3
- …
- 73
- Next Page »
